Systemic adjuvant therapies in renal cell carcinoma

Renal cell carcinoma (RCC) is one of the ten most frequent solid tumors worldwide. Recent innovations in the treatment of metastatic disease have led to new therapeutic approaches being investigated in the adjuvant setting. Observation is the only current standard of care after radical nephrectomy,...

Descripción completa

Detalles Bibliográficos
Autores principales: Buti, Sebastiano, Bersanelli, Melissa, Donini, Maddalena, Ardizzoni, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419621/
https://www.ncbi.nlm.nih.gov/pubmed/25992216
http://dx.doi.org/10.4081/oncol.2012.e18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419621/
https://www.ncbi.nlm.nih.gov/pubmed/25992216
http://dx.doi.org/10.4081/oncol.2012.e18

Ejemplares similares